EDITORIAL SECTION

Articles

B2B Lead Generation Pharma: High-ROI Tactics for European Markets

The European pharmaceutical industry can be called one of the most complicated and highly regulated markets in the world In the global market where a centralized approval system under the oversight of the European Medicines Agency EMA is required to the reimbursement systems specific to each country in Germany France Italy Spain and the Nordics market entry and market growth needs the accuracy of...

Market Access Strategies for Pharma Products in Europe: A Comprehensive Guide

The European pharmaceutical market is dynamic and diverse presenting both opportunities and challenges for companies seeking market access This guide delves into effective strategies for navigating the complexities of market access in Europe focusing on key aspects such as reimbursement pricing and overcoming market entry challenges

Navigating European Pharma Regulations: A B2B Perspective

The pharmaceutical industry in the European region practices one of the most regulating laws in the entire world Therefore regulations encompassing these areas are of prime importance for BB companies that need to achieve market entry and maintain compliance Thus this guide is meant to decompartmentalize the array of European pharma regulations and create

Breaking Down Barriers: Advancements in Biodegradable Drug Delivery

In todays world where sustainability is a top priority breaking down barriers to a greener future is crucial One area where advancements are being made is in the field of biodegradable drug delivery

The Competitive Generic Therapy (CGT)

Generic medications are critical in the healthcare sector due to their affordability and accessibility to the public while maintaining comparable quality efficacy and safety to that of branded products Generic medications research and development followed by commercialisation also fosters competition and innovation within the pharmaceutical

How to Mitigate Operational Risks in the Pharma Industry?

The operation of the pharmaceutical industry has significant risks with the most probable being operational risks These risks include supply chain interruption regulatory non compliance product defects technological disruption The development of strategies to avoid compromise in operations remains paramount not only in protecting the customers from harm or receiving

Techno Trends

FDA Approves Regeneron’s First-in-Class Gene Therapy for OTOF Hearing Loss

Regeneron Pharmaceuticals has received FDA accelerated approval lunsotogene parveccwha a gene therapy for patients with severetoprofound sensorineural hearing loss caused by OTOF gene mutations

Projects

Boehringer Ingelheim Invests £150 Million to Expand Global AI Footprint in the UK

Boehringer Ingelheim is expanding its global Computational Innovation network with a new artificial intelligence AI and machine learning ML centre in Kings Cross London

Research Insights

Knowledge gaps and positive attitudes toward adult vaccination among nursing students: A Cross-sectional study

Vaccination is one of the most effective publichealth measures yet adult coverage in Spain remains suboptimal due to misinformation and hesitancy

whitepaper

Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch

Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities